|
| |
Recent Publications on Virotherapeutics: |  |
Development of targeted oncolytic virotherapeutics through translational research.
BACKGROUND: Oncolytic virotherapeutics is a promising platform for cancer...
Direct Link | 29th October, 2008
| Jennerex Biotherapeutics, One Market Street, Spear Tower, Suite 2260, San
|
Translation of targeted oncolytic virotherapeutics from the lab into the clinic, and back again: a high-value iterative loop.
BACKGROUND: Oncolytic virotherapeutics is a promising platform for cancer...
Direct Link | 20th August, 2008
| 1Jennerex Biotherapeutics, San Francisco, California, USA.
|
Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963.
Replication-selective oncolytic viruses (virotherapeutics) are being...
Direct Link | 3rd April, 2008
| Department of Pediatrics and Bio-X Program, James H. Clark Center,
|
Cell-based delivery of oncolytic viruses: a new strategic alliance for a biological strike against cancer.
Recent years have seen tremendous advances in the development of...
Direct Link | 23rd May, 2007
| Department of Biochemistry, Microbiology and Immunology, University of
|
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress.
Therapeutic oncolytic viruses (virotherapeutics) constitute a novel class...
Direct Link | 7th March, 2007
| Jennerex Biotherapeutics, One Market Street, Spear Tower, Suite 2260, San
|
Oncolytic viruses for the treatment of cancer: current strategies and clinical trials.
Tumor-selective replicating viruses offer appealing advantages over...
Direct Link | 16th December, 2004
| University of Muster, Department of Medicine, Hematology and Oncology,
|
Virotherapeutics: conditionally replicative adenoviruses for viral oncolysis.
Viral oncolysis, or virotherapy, is an endeavor to use viruses as...
Direct Link | 18th March, 2004
| Department of Dermatology, University of Erlangen-Nuremberg, Erlangen,
|
|
